Advanced Filters
noise

Kronisk bronkitis (KOL)/ Rygerlunger Clinical Trials

A listing of Kronisk bronkitis (KOL)/ Rygerlunger medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 103 clinical trials

Sacral Fracture Fusion/Fixation for Rapid Rehabilitation

To determine the safety and efficacy of concomitant sacral fracture fixation and sacroiliac (SI) joint fusion vs. non-surgical management for patients with debilitating sacral fragility or insufficiency fractures

60 - 100 years of age Both Phase N/A
J John Ko, M.Sc

Finding the Optimal Resistance Training Intensity For Your Bones

Osteoporosis is a bone disease that can result in fractures, disability and an increased risk of premature death. Exercise is recommended for fall and fracture prevention, but health care professionals often recommend walking or lower intensity community exercise classes, which may not be effective for building bone. Further, individuals with …

50 - 100 years of age Both Phase N/A
J Jacintha Domic, MSc

The Effect of a 12-week Self-composed Vegan Diet With or Without Concurrent Resistance Exercise on Thigh Muscle Volume in Older Adults

Consumers are increasingly encouraged to consume more plant-based foods and lower their consumption of foods from animal origin. This shift is driven by environmental and health factors. However, the consequences of such a transition on muscle mass still remains to be explored. This is of particular importance in the older …

65 - 100 years of age Both Phase N/A
K Kimberly K Owens, MPH

Mode of Exercise and Bone Biomarkers in Older Veterans

Adults are often encouraged to exercise to maintain or improve bone health. However, there is evidence that exercise does not always lead to increases in bone mass, and exercise could lead to bone loss under certain conditions. Endurance exercise can increase bone resorption following an exercise bout, which may explain …

60 - 100 years of age Both Phase N/A
E Elise B Vesterhus, RN

Zoledronate Early to Hip Fracture Patients - Safe and Effective?

To prevent hip fracture patients for having another fracture, secondary fracture preventing medication should be given as soon as possible. Zoledronate is the most efficient bisphosphonate and is given as an intravenous infusion once yearly. However, the appropriate time to initiate zoledronate treatment after a hip fracture has not yet …

50 - 100 years of age Both Phase 4
A Antonio J Ortiz-Ruiz, MD

Minimally Invasive Sinus Lift Through the Interradicular Septum

This study aims to describe a new approach for the reconstruction of the alveolar process in the sinus area. This minimally invasive approach will access the maxillary sinus through the alveolar process, elevating the sinus membrane in the area immediately above it. The regeneration may be achieved in the specific …

18 - 100 years of age Both Phase N/A
L Lise Laclautre

Cardiovascular Risk in Digital Osteoarthritis

The goal of this cross-sectional case control study is to investigate the cardiovascular risk in digital osteoarthritis. This study aims to compare the cardiovascular risk between group of patients with digital osteoarthritis and control group of patients with non-osteoarthritis disease paired by measurement of carotid intima-media thickness. All participants will …

18 - 100 years of age Both Phase N/A
I Idoia Labayen, PhD

Effects of Time-restricted Eating and Exercise Training on Skeletal Muscle Mass Quantity, Quality and Function in Postmenopausal Women With Overweight and Obesity

The goal of this randomized controlled trial] is to investigate the effects of a 12-week time restricted eating (TRE) and exercise combined intervention, as compared to (i) TRE alone, and to (ii) Caloric Restriction (CR) plus the same exercise intervention elicited by the TRE group, on Skeletal muscle tissue (SMT) …

50 - 65 years of age Female Phase N/A
S Steven C Kirshblum, M.D.

Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

18 - 55 years of age Both Phase 4
S Steven C Kirshblum, M.D.

Treatment With Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI

The objective of the proposed work is to determine whether administration for 12 months of romosozumab (evenity) followed by 12 months of denosumab (prolia) will maintain bone mass at the knee in subjects with chronic SCI.

18 - 55 years of age Both Phase 4

Rewrite in simple language using AI